News & Events
-
October 14, 2015
Parkinson’s UK and Critical Path Institute Launch the Critical Path for Parkinson’s (CPP) Consortium
October 14, 2015 Parkinson’s UK and Critical Path Institute Launch the Critical Path for Parkinson’s (CPP) Consortium Data from past Parkinson’s trials will be collected, standardized, and integrated, in order to inform new approaches to designing clinical trials focused on early-stage Parkinson’s. London and Tucson – October 14, 2015 – Parkinson’s UK, one of the...... -
August 30, 2015
Critical Path Institute’s Polycystic Kidney Disease Outcomes Consortium Secures FDA Qualification for Enrichment Biomarker in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
August 31, 2015 Critical Path Institute’s Polycystic Kidney Disease Outcomes Consortium Secures FDA Qualification for Enrichment Biomarker in Autosomal Dominant Polycystic Kidney Disease (ADPKD) TUCSON, Ariz., August 31, 2015 – The Critical Path Institute (C-Path) announced today that the U.S. Food and Drug Administration (FDA) has issued a qualification decision in the form of a...... -
August 19, 2015
AZBio Honors Lynn Hudson, Ph.D. Of Critical Path Institute As 2015 Arizona Bioscience Leader
August 19, 2015 AZBio Honors Lynn Hudson, Ph.D. Of Critical Path Institute As 2015 Arizona Bioscience Leader August 19, 2015 – Citing her leadership in advancing extremely complex biomedical research, the Arizona BioIndustry Association today announced that Lynn Hudson, Ph.D., Chief Science Officer for the Critical Path Institute, will be honored with the Jon W....... -
August 3, 2015
Critical Path Institute Launches New Consortium Dedicated To Duchenne Muscular Dystrophy
August 3, 2015 Critical Path Institute Launches New Consortium Dedicated To Duchenne Muscular Dystrophy Tucson, Arizona – August 3, 2015: Critical Path Institute (C-Path), a pioneering non-profit organization dedicated to accelerating the pace and reducing the costs of medical product development, announced the formation of its tenth consortium: The Duchenne Regulatory Sciences Consortium (D-RSC). In...... -
July 23, 2015
CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia
July 23, 2015 CDISC Releases Clinical Research Data Standards for Schizophrenia, Hepatitis C and Dyslipidemia Austin, TX – 23 July 2015 – The Clinical Data Interchange Standards Consortium (CDISC), the Critical Path Institute (C-Path), and TransCelerate BioPharma, Inc. are pleased to announce that data standards for clinical research in the areas of Schizophrenia, Hepatitis C......